Last Updated: June 22, 2026

CARBINOXAMINE Drug Patent Profile

Name: CARBINOXAMINE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Carbinoxamine patents expire, and when can generic versions of Carbinoxamine launch?

Carbinoxamine is a drug marketed by Cypress Pharm, Genus, Ph Health, Leading, Mikart, Mission Pharmacal, Senores Pharms, and Strides Pharma Intl. and is included in ten NDAs.

The generic ingredient in CARBINOXAMINE is carbinoxamine maleate. There are seven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Carbinoxamine

A generic version of CARBINOXAMINE was approved as carbinoxamine maleate by GENUS on March 19^th, 2003.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CARBINOXAMINE?
What are the global sales for CARBINOXAMINE?
What is Average Wholesale Price for CARBINOXAMINE?

Summary for CARBINOXAMINE

US Patents:	0
Applicants:	8
NDAs:	10
Drug Prices:	Drug price information for CARBINOXAMINE
DailyMed Link:	CARBINOXAMINE at DailyMed

Drug patent expirations by year for CARBINOXAMINE

US Patents and Regulatory Information for CARBINOXAMINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cypress Pharm	CARBINOXAMINE MALEATE	carbinoxamine maleate	SOLUTION;ORAL	090418-001	May 4, 2010		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Mikart	CARBINOXAMINE MALEATE	carbinoxamine maleate	TABLET;ORAL	207484-001	May 31, 2016	AA	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Cypress Pharm	CARBINOXAMINE MALEATE	carbinoxamine maleate	TABLET;ORAL	090417-001	Aug 23, 2010		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for CARBINOXAMINE

Carbinoxamine maleate 6 mg?
Cheap carbinoxamine maleate?
Carbinoxamine maleate price?
Carbinoxamine maleate info?
Carbinoxamine maleate discount?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.